Home/Filings/4/0001104659-20-113186
4//SEC Filing

5AM Ventures IV, L.P. 4

Accession 0001104659-20-113186

CIK 0001781983other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 9:30 PM ET

Size

20.7 KB

Accession

0001104659-20-113186

Insider Transaction Report

Form 4
Period: 2020-10-05
Transactions
  • Sale

    Common Stock

    2020-10-05$25.30/sh175,000$4,427,500138,497 total(indirect: See footnotes)
Holdings
  • Common Stock

    (indirect: See footnotes)
    75,965
  • Common Stock

    (indirect: See footnotes)
    1,823,192
Footnotes (5)
  • [F1]Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.
  • [F2]5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.
  • [F3]Shares are held directly by 5AM Ventures IV, L.P.
  • [F4]5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Dr. Scott M. Rocklage and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.
  • [F5]Shares are held directly by 5AM Co-Investors IV, L.P.

Documents

1 file

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001589315

Filing Metadata

Form type
4
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 9:30 PM ET
Size
20.7 KB